Skip to content

Opening book details…

About this Medicine article

Comment on: ‘Lupus Low Disease Activity State (LLDAS) attainment discriminates responders in a systemic lupus erythematosus trial: post-hoc analysis of the Phase IIb MUSE trial of anifrolumab’ by Eric Morand et al by Isenberg, David is a Medicine article available to read on EtoBox.

It is typically read by researchers, students, and practitioners in Medicine.

Author
Isenberg, David
Publisher
BMJ Publishing Group; BMJ (ISSN 0003-4967)
Published
2018
Field
Medicine (Health Sciences)

More by Isenberg, David

Browse all works by Isenberg, David